No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Progen Holdings Faces Strategic Challenges Amid Revenue Growth
Profluent Introduces ProGen3, Demonstrating Scaling Laws for Foundation Models in Writing Biology
Progen: Annual Reports and Related Documents
Progen: Financial Statements and Related Announcement-Full Yearly Results
Progen to Turn to Profit in H2 2024; Shares Up 7%
Prostatype Genomics' Medicare Reimbursement Application Reaches Final Stage